Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is for anyone who wants confirmation on a FINRA filing... Like I said before, tentative filings/information isn't available... You can't search for it... Come on guys be smarter than that...
Yes. With penny stocks in general it's all about momentum. This is a completely different play: it's a mid-term hold (hopefully it's safe to call it a short-term hold now )
Most penny stock traders don't "hold." In fact it's ill advised by many to actually "hold" penny stocks... They're get in, get out kinda stocks.
If there's no change/news by the end of the month, I'll be antsy and might go ahead and dump my shares too. But there's still plenty of time for that so I'm not sweatin it right now and I'm content holding. I'm just leaving this one on the back burner til then.
Are you calling yourself a joke?
This board has turned into a joke.
Long.
See ya'll on the flip side.
Make it 17 out of 18 trades today are sells...
That's very respectable that you followed your strategy. Stick to your rules and guidelines - they're what make successful traders!
CHEERS!
And this is why I barely visit this board... Just read through 40 junk messages...
If you're unhappy then DUMP you shares and move on. Take the loss. Everyone has their own ideals and expectations. Whining won't change anything. It doesn't make the stock go up or go down. There are a lot more buyers (and sellers) then the handful of people that view this board...
Seriously. Dump your shares. Chalk up the loss (or profit) and move on to the next stock message board you can whine on.
Holding and patience is something that a lot of traders lack and it's pretty evident which trader's those are on this board.
You're making a fool of yourself.
Cheers.
Scott
This is not a P&D .... It lacks every single characteristic that makes up a P&D .... You're out so you should just bounce out .... Completely.
Cheers.
Scott
VFIN's the punk.
Medbox Featured on WSJ's MarketWatch
http://www.otcmarkets.com/stock/MDBX/news?id=67188
"Shareholders have benefited from legalization"
PR Newswire
HOLLYWOOD, Calif., Aug. 12, 2013
HOLLYWOOD, Calif., Aug. 12, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented inventory control, compliance, and dispensing systems to the medical and retail industries, announced that they have been featured in The Wall Street Journal MarketWatch.
The article states that the medical marijuana industry, now legal in 20 states and Washington, D.C., could double next year, to $3 billion. "And owners and shareholders of some companies — including Medbox (MDBX), whose stock is up more than 800% in the past year, has certainly benefited from legalization."
The article points out that under federal law, selling, producing, possessing and consuming marijuana is still a crime. However, Medbox is not engaged in the business of selling, producing, processing or consuming marijuana, and makes its revenues through consulting and sales of its patented inventory control system. This important distinction may be one of the reasons why Medbox has become a darling stock on Wall Street.
Furthermore, shareholder and company growth may be fueled by increased acceptance of medical marijuana nationwide, and shifting trends that point out that marijuana is not the evil, addictive substance it was once portrayed to be.
In fact, according to the latest research from the Gallup Organization, fewer young people are trying cannabis now than in 1985.
As reported by the Huffington Post, "In 1985, 56 percent of Americans aged 18-29 had tried marijuana. The figure now for that age group is just 36 percent."
"The data also dismisses the myth that making marijuana legal will encourage use, especially by young people," Dr. Bruce Bedrick, CEO of Medbox commented. "Medical marijuana has a legitimate place in a doctor's arsenal to treat a variety of serious conditions."
CNN Chief Medical Correspondent Dr. Sanjay Gupta made headlines last week when he wrote that he changed his mind and was now in favor of medical marijuana.
"I mistakenly believed the Drug Enforcement Agency listed marijuana as a Schedule 1 substance because of sound scientific proof," Dr. Gupta penned. "They didn't have the science to support that claim, and I now know that when it comes to marijuana, it doesn't have a high potential for abuse, and there are very legitimate medical applications. In fact, sometimes marijuana is the only thing that works," he added.
"We have been terribly and systematically misled for nearly 70 years in the United States, and I apologize for my own role in that," Dr. Gupta wrote.
Until 1943, marijuana was part of the United States drug pharmacopeia. One of the conditions for which it was prescribed was neuropathic pain. "It is a miserable pain that's tough to treat," Gupta said. "While marijuana has long been documented to be effective for this awful pain, the most common medications prescribed today come from the poppy plant, including morphine, oxycodone and dilaudid," he added.
"Here is the problem," Gupta stated. "Most of these medications don't work very well for this kind of pain, and tolerance is a real problem."
"Most frightening to me is that someone dies in the United States every 19 minutes from a prescription drug overdose, mostly accidental. Every 19 minutes. It is a horrifying statistic. As much as I searched, I could not find a documented case of death from marijuana overdose," Gupta said.
"It is perhaps no surprise then that 76% of physicians recently surveyed said they would approve the use of marijuana to help ease a woman's pain from breast cancer."
As for the future, Gupta wrote, "Looking forward, I am especially intrigued by studies like those in Spain and Israel looking at the anti-cancer effects of marijuana and its components. I'm intrigued by the neuro-protective study by Lev Meschoulam in Israel, and research in Israel and the United States on whether the drug might help alleviate symptoms of PTSD," he added. "I promise to do my part to help, genuinely and honestly, fill the remaining void in our knowledge."
"As more states consider legalizing medical marijuana, we hope the myths of the past will be replaced by the science of the present," Dr. Bedrick commented. "And that patients who could benefit from this natural plant will not be denied access."
For more information on Medbox, visit: www.thedispensingsolution.com.
To view the Wall Street Journal MarketWatch article, visit: http://www.marketwatch.com/story/10-things-medical-marijuana-wont-tell-you-2013-08-09?pagenumber=1
To read the Huffington Post article, visit: http://www.huffingtonpost.com/russ-belville/marijuana-legalization_b_3709636.html?ncid=edlinkusaolp00000009
To read Dr. Sanjay Gupta's article on CNN, visit: http://www.cnn.com/2013/08/08/health/gupta-changed-mind-marijuana
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.
SOURCE Medbox, Inc.
PRE14C: Reverse Split~ Ratio in the range 1-for-50 and 1-for-100
(1) to effect, at the discretion of our Board, a reverse stock split (pro-rata reduction of outstanding shares) of Common Stock at a reverse split ratio in the range of between 1-for-50 and 1-for-100 (the “Reverse Stock Split”), which specific ratio will be determined by the Chairman of our Board prior to filing the Restated Articles (as defined below);
(2) to fix the number of authorized shares of Common Stock after the Reverse Stock Split at one hundred and fifty million (150,000,000) shares of Common Stock (the “Common Stock Increase”), which change will result in an increase in the authorized number of shares of Common Stock;
(3) to authorize the issuance of fifty million (50,000,000) shares of “blank check” preferred stock, $0.001 par value per share (the “Preferred Stock”), to be issued in series, and all properties of such Preferred Stock to be determined by the Company’s Board (the “Preferred Stock Authorization”);
(4) to change the name of the Company to “Lion Biotechnologies, Inc.” (the “Name Change”);
(5) to amend the Company’s Articles of Incorporation to add indemnification and limit the personal liability of officers and members of our Board (the “Indemnification”); and
(6) to approve an amendment to our 2011 stock option plan (a) increasing the number of shares of Common Stock authorized for issuance under the Genesis Biopharma, Inc. 2011 Equity Incentive Plan (the “Option Plan”) from 18,000,000 shares of Common Stock to 170,000,000 shares of Common Stock (prior to giving effect to the Reverse Stock Split), (b) increasing the maximum number of shares eligible for issuance under the Option Plan in any twelve-month period from 5,000,000 shares of Common Stock to 30,000,000 shares of Common Stock (prior to giving effect to the Reverse Stock Split) and (c) changing the name of the Option Plan to reflect the Name Change (collectively, the “Option Plan Amendment”).
www.sec.gov/Archives/edgar/data/1425205/000151316013000046/gnbpsc14c.htm
~
Sorry. Delayed. Turned on my comp saw it in RSS aggregator from tonight.
OTC:TDEY QUARTERLY REPORT (PDF)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=109237
You can search for rules, guidelines, and existing information, etc. on the FINRA site, but you can't search for tentative filings, pre-approved, pre-finalized filings... If that were the case FINRA's website would be pure GOLD!
With this uber low float, low volume, thin trading (especially where we're at now near the top of new highs) resistance is non-existent. I was just looking at the chart and saw that it touched/tested .036 and retraced and touched/tested .04 and retraced. Only touched/tested each price one time though... I like to see AT LEAST two tests.. At least...
Are you kidding me?!
Look at a chart and draw some lines... .034 isn't even in NXHZ's vocabulary. Post a chart of NXHZ and plot a line that shows how NXHZ hit's .034 but can't break through it, hence defining it as resistance... You can't do this b/c NXHZ hasn't hit resistance at .034... It's blown through it and bounced off .036 and .04, but not .034.
Everyone charts differently, but your's lacks logic. "We can't hit .034" would imply that .033 was a resistance level. Hell, if NXHZ drops in price Monday you could say .033 is a resistance level! But not .034... Still...
Should be clear sailing to .04 ~ technically if you want a resistance level I believe it would be .04, but since this stock is going to be moving on pure momentum and glorious news, we'll just consider it a break out or supernova now
It's not hitting .034 NOT b/c it is a resistance level but because MMs are ask sitting.
Big difference...
Momoney, if you know how to read charts to plot where support and resistance levels are, then you'd notice that .034 is not a resistance level. If you want a resistance level the closest ones are .036 and .04 ...
Learn to reach charts. Barchart is never accurate ESPECIALLY when they start talking about resistance and support levels... They just average out prices... They don't takes charts into consideration and that is how resistance and support levels are determined.
Technical analysis 101
Could get filled... One MM leaves one stays... Maybe they both leave after 30k fill ... Maybe only 20k fills who knows!
From watching L2's ~ 10k shares sizes are the 'fake' sizes MM's use. They could each have a couple hundred thousand shares and may just move off the .33's ... Anyone's guess.
MMs have fake ASK sizes plastered all over the L2 ~ they'll move 'em with some pressure though.
.034 is definitely not the a resistance level ~ just look at the chart.
Rock it skunk! Slap that b*tch (aka ASK!)
that was the weakest wack I've ever seen lol
I appreciate the apology. Some of us make more mistakes than others, but it's how you bounce back that defines you.
I believe this is the last week of "NXHZ" trading....
$DVR 40 million dollar contract awarded ~ watch morning gap
$NXHZ Symbol Change/Uranium Acquisitions/Merger News By EOW
$NXHZ Symbol Change/Uranium Acquisitions/Merger News By EOW
$NXHZ Symbol Change/Uranium Acquisitions/Merger News By EOW
Last week to buy "$NXHZ"
Last week to buy "$NXHZ"
Last week to buy "$NXHZ"
A little behind, but what do you expect a lot's going on!
Yeah, so? What's you point? You upset because I'm way better off than you?! LMAO! I'm tired of whining, bitching, and moaning from weak hands like you!
$NUGT killed it today. Look for a nice GAP tomorrow
Why don't you just dump your shares - you're the new negativity on the board.
momoney you don't even deserve a response to that.